CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
News | Holter Monitoring Systems
RhythMedix Expands Monitoring Capabilities of Its RhythmStar System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity

October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms ...

Home October 25, 2022
Home
Asher Kimchi, MD: 1946-2022
News | Cardiovascular Business
Founder, Medical Co-Director of Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute Remembered

October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine ...

Home October 24, 2022
Home
CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
News | Hypertension
CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research

October 24, 2022 — CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly ...

Home October 24, 2022
Home
Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program
News | Cardiovascular Surgery
Vascular Surgeon to Lead, Train Fellows

October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as ...

Home October 24, 2022
Home
Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated announced submission of pivotal clinical data from the AcQForce Flutter trial
News
Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter and System

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.
News | Cardiogenic Shock
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure

October 21, 2022 — Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post ...

Home October 21, 2022
Home
Medtronic “Conduction System Pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates
News | Catheter
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System

October 21, 2022 — Medtronic plc, a global leader in healthcare technology, today announced it has received U.S. Food ...

Home October 21, 2022
Home
A composite photo demonstrating how mixed reality visualization would be combined with robotic surgery in an MRI.
News | Robotic Systems
Mixed-Reality Robotic Heart Surgery Inside an MRI?

October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National ...

Home October 20, 2022
Home
The American Heart Association to enable a wide range of research with real-time data from acute care hospitals
News | Cardiogenic Shock
New Data Registry Collects Evidence in Cardiogenic Shock Patients

October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet ...

Home October 20, 2022
Home
MedAtlas CV will transform cardiovascular care delivery and expand patient access
News | Cardiovascular Business
Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV

October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers ...

Home October 20, 2022
Home
After dedicating the last 28 years to building one of the world’s leading cardiovascular centers, Dr. Fuster will continue to advance the clinical care, research, and innovative training at Mount Sinai Heart. Image courtesy of Mount Sinai Health System
News | Cardiovascular Business
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart

October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named ...

Home October 19, 2022
Home
Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista
News | ECG
HeartSciences Announces Major Milestone with the Issuance of CPT Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction

October 19, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving ...

Home October 19, 2022
Home
For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.
News | Heart Failure
Cardiovascular Disease Risks the Same in Both Sexes

October 19, 2022 — For men and women, the risk factors for cardiovascular disease are largely the same, an extensive ...

Home October 19, 2022
Home
HeartFlow is the first and only company to provide non-invasive anatomy, physiology, and plaque information based on coronary computed tomography angiography (CCTA)
News | Cardiac Imaging
HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap Analysis

October 18, 2022 — HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug ...

Home October 18, 2022
Home
Gregory D. Casciaro
News | Heart Valve Technology
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer

October 18, 2022 — Foldax, Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive ...

Home October 18, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now